Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare
Fennec Pharmaceuticals Inc. EBITDA 2011–2025
Fennec Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2011 to 2014. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Fennec Pharmaceuticals Inc. ebitda for the quarter ending September 30, 2014 was -619000, a 1113.73% increase year-over-year.
- Fennec Pharmaceuticals Inc. ebitda for the twelve months ending September 30, 2014 was -2.1 M, a 36.09% decrease year-over-year.
- Fennec Pharmaceuticals Inc. annual ebitda for 2013 was -1.9 M, a 46.66% decrease from 2012.
- Fennec Pharmaceuticals Inc. annual ebitda for 2012 was -3.6 M, a 5.29% increase from 2011.
- Fennec Pharmaceuticals Inc. annual ebitda for 2011 was -3.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fennec Pharmaceuticals Inc. EBITDA — FAQ
Fennec Pharmaceuticals Inc. (FENC) ebitda over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FENC's ebitda history?
The chart and table above show Fennec Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.